SCHEMBL7628474

SCHEMBL7628474

O=Cc1[c]c(O)cc2ccccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 6/20 0.42
TRPM4 Q8TD43 1/20 0.39
NQO2 P16083 1/20 0.38
ALDH1A1 P00352 3/20 0.37
CYP1A2 P05177 3/20 0.37
KMT2A Q03164 3/20 0.37
HSD17B10 Q99714 2/20 0.37
KDM4E B2RXH2 2/20 0.37
MEN1 O00255 2/20 0.37
HPGD P15428 2/20 0.37
PADI4 Q9UM07 1/20 0.37
GLA P06280 1/20 0.37
CYP2C19 P33261 1/20 0.37
CASP6 P55212 1/20 0.35
HIF1A Q16665 1/20 0.34
CYP1B1 Q16678 1/20 0.34
CYP2A6 P11509 1/20 0.34
MAPT P10636 1/20 0.34
MPI P34949 1/20 0.34
NQO1 P15559 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5032934 0.76 TRPM4 (0.48) TRPM4NQO2ALDH1A1CYP1A2KMT2A
SCHEMBL29019737 0.71 TRPM4 (0.43) TRPM4NQO2ALDH1A1CYP1A2KMT2A
SCHEMBL692620 0.70 MEN1 (0.50) TRPM4NQO2ALDH1A1CYP1A2KMT2A
SCHEMBL5411002 0.69 KDM4E (0.43) TRPM4NQO2ALDH1A1CYP1A2KMT2A
SCHEMBL6631799 0.69 CYP2D6 (0.47) TRPM4NQO2ALDH1A1CYP1A2KMT2A
SCHEMBL342713 0.67 ERN1 (0.41) ERN1ALDH1A1CYP1A2KMT2AHSD17B10
SCHEMBL5888951 0.67 TRPM4 (0.36) TRPM4NQO2ALDH1A1KMT2AHSD17B10
SCHEMBL7565940 0.66 TRPM4 (0.38) TRPM4NQO2ALDH1A1CYP1A2KMT2A
SCHEMBL5841822 0.65 ERN1 (0.63) ERN1TRPM4NQO2CYP1A2KDM4E
SCHEMBL3268303 0.65 NQO2 (0.55) ERN1TRPM4NQO2ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6410766-B1 None US disclosed
US-6410766-B2 AN ORGANOMETALLIC COMPLEX CONTAINING A HYDROXYQUINOLINE OR 2-(O-HYDROXYPHENYL)-BENZOXAZOLE BIDENTATE LIGAND AND SECOND AND THIRD LIGAND IS A SUBSTITUTED OR NONSUBSTITUTED ARYL GROUP; THREE CHELATE ATOMS, TWO OXYGEN AND ONE NITROGEN ATOM TSINGHAU UNIVERSITY (CN) 2002-06-25 US disclosed
US-20010037024-A1 Emitting materials used for organic EL based on tridentate ligands TSINGHUA UNIVERSITY (CN) 2001-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010037024-A1 Emitting materials used for organic EL based on tridentate ligands SLC1A1, SLCO2A1, SLCO1A2 ERN1 3335/4885TRPM4 794/4885NQO2 2479/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.